Corporate insider profile
Edward J Dulac III Insider Trades
Latest reported as EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$175,434.75
- Latest transaction
- Jul 22, 2026
Affiliated corporations
Reported company relationships
Transaction history
